Immunoglobulin synthesis and tumor kinetics of multiple myeloma.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Seminars in hematology (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 4266778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy of mouse myeloma: quantitative cell cultures predictive of response in vivo.

  1973cited by this paper
• Kinetics of tumor growth and regression in IgG multiple myeloma.

  1972cited by this paper
• Chalones: chemical regulation of cell division.

  1972cited by this paper
• The effect of plasmacytomas on the immune response of mice.

  1972cited by this paper
• Modes of escape from therapeutic control in myelomatosis.

  1971cited by this paper
• Mouse myeloma tumor stem cells: a primary cell culture assay.

  1971cited by this paper
• Immunocytoma o' mice an' men.

  1971cited by this paper
• IgE myeloma: total body tumor cell number and synthesis of IgE and DNA.

  1971cited by this paper
• Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

  1970cited by this paper
• Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma.

  1970cited by this paper
• Immunoglobulin Production: Method for Quantitatively Detecting Variant Myeloma Cells

  1970cited by this paper
• Kinetic parameters and growth curves for experimental tumor systems.

  1970cited by this paper
• Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.

  1969cited by this paper
• The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.

  1969cited by this paper
• Growth Rates and Responses to Treatment in Human Myelomatosis

  1969cited by this paper
• Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755.

  1969cited by this paper
• Factors pertaining to complete drug-induced remission of tumor in animals and man.

  1969cited by this paper
• Metabolism of immunoglobulins.

  1969cited by this paper
• "Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins.

  1969cited by this paper
• Role of gamma globulin for immunoprophylaxis in multiple myeloma.

  1967cited by this paper
• Dynamics of Tumour Growth: Comparison of Growth Rates and Extrapolation of Growth Curve to One Cell

  1965cited by this paper
• Dynamics of Tumour Growth

  1964cited by this paper
• INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA.

  1963cited by this paper
• Cell proliferation in multiple myeloma studied with tritiated thymidine in vivo.

  1962cited by this paper

• T-cell exhaustion due to BiTE therapy in multiple myeloma: mitigating infectious risks through treatment-free intervals

  2026cites this paper
• Determining Optimal Combination Regimens for Patients with Multiple Myeloma.

  2022cites this paper
• Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma

  2016cites this paper
• Vaccination of multiple myeloma: Current strategies and future prospects.

  2015cites this paper
• Epidemiology of Infections in Cancer Patients

  2014cites this paper
• Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.

  2012cites this paper
• Idiotype‐pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

  2009cites this paper
• Battling the hematological malignancies: the 200 years' war.

  2008cites this paper
• Genetic events in the pathogenesis of multiple myeloma.

  2007cites this paper
• Complications of myeloma therapy.

  2007cites this paper
• Excision of Extramedullary Plasmacytoma in a Hilar Lymph Node

  2006cites this paper
• Genomics in multiple myeloma: biology and clinical implications.

  2005cites this paper
• Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report

  2004cites this paper
• Genetics and Cytogenetics of Multiple Myeloma

  2004cites this paper
• Lymphoid malignancies: immunophenotypic analysis.

  2003cites this paper
• Accuracy of serum IgM and IgA monoclonal protein measurements by densitometry.

  2003cites this paper
• Erythema elevatum diutinum and IgA paraproteinaemia: ‘a preclinical iceberg’

  2002cites this paper
• Interleukin-l0 Is a Proliferation Factor But Not a Differentiation Factor for Human Myeloma Cells

  2002cites this paper
• Tinea pedis resulting from Fusarium spp.

  2002cites this paper
• Primary pulmonary plasmacytoma: a case report.

  2001cites this paper
• Pulmonary edema associated with hyperbaric oxygen therapy.

  2001cites this paper
• Spontaneous monoclonal immunoglobulin‐secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma

  2000influential citation
• Evaluation of argyrophilic nucleolar organiser regions (AgNORs) in multiple myeloma

  2000influential citation
• Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy.

  1999cites this paper
• Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study

  1999cites this paper
• Epidemiology of infectious complications in cancer patients.

  1998cites this paper
• Interleukin-4 and tumour necrosis factor-alpha produce non isotype specific partial differentiation of peripheral blood B-cells in myeloma.

  1998cites this paper
• Pulmonary plasmacytomas: a clinicopathologic and immunohistochemical study of five cases.

  1998cites this paper
• Immunoregulatory mechanisms in multiple myeloma.

  1997cites this paper
• New insights in the clinical biology of multiple myeloma.

  1997cites this paper
• Underestimation of monoclonal proteins by agarose serum protein electrophoresis.

  1997cites this paper
• Taking the X out of histiocytosis X.

  1997cites this paper
• Multiple myeloma.

  1997cites this paper
• Plateau phase in multiple myeloma: an analysis of long‐term follow‐up of 432 patients

  1996influential citation
• Prognostic value of serum M‐protein doubling time at escape from plateau of multiple myeloma

  1996influential citation
• Prognostic value of serum M-protein doubling time at escape from plateau of multiple myeloma. The Finnish Leukaemia Group.

  1996cites this paper
• Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.

  1996cites this paper
• Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.

  1995cites this paper
• Interleukin-6 in human multiple myeloma.

  1995cites this paper
• Kinetics of paraprotein clearance after autografting for multiple myeloma.

  1995cites this paper
• High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma.

  1994cites this paper
• Effect of vincristine, adriamycin and glucocorticoids on myeloma cells in vitro.

  1993cites this paper
• Biology and treatment of multiple myeloma.

  1993cites this paper
• Prognostic value of the plasma cell synthesis score in multiple myeloma.

  1992cites this paper
• Second and third responses to the same induction regimen in relapsing patients with multiple myeloma

  1991cites this paper
• Gammopathy

  1991influential citation
• Superior vena cava syndrome caused by an intrathoracic plasmacytoma

  1991cites this paper
• Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.

  1990cites this paper
• Immunosuppression and Human Malignancy

  1990cites this paper
• Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.

  1990cites this paper
• Altered cytokine activities are related to the suppression of synthesis of normal immunoglobulin in multiple myeloma

  1989cites this paper
• Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

  1989cites this paper
• Weight loss, anemia, elevated paraprotein levels, and renal failure in a 61-year-old man.

  1989cites this paper
• Quantitation of tumor response to anti-neoplastic therapy.

  1988cites this paper
• Separation of human myeloma cells from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitro.

  1988cites this paper
• M‐2 protocol for melphalan‐resistant and relapsing multiple myeloma

  1988cites this paper
• Radiotherapy in the treatment of multiple myeloma.

  1988cites this paper
• Serum immunoglobulin E levels in patients with head and neck cancer

  1988cites this paper
• Spontaneous regression of extramedullary plasmacytoma —A case report

  1988cites this paper
• Characterization of a low molecular weight suppressor of lymphocyte proliferation from guinea pig L2C leukemia cells.

  1987cites this paper
• Underestimation of monoclonal proteins by serum protein electrophoresis on cellulose acetate.

  1987cites this paper
• [Immunology of myeloma].

  1987cites this paper
• Management of myeloma kidney: an anti-light-chain approach.

  1987cites this paper
• Multiple myeloma: biological and clinical significance of bone marrow plasma cell labelling index.

  1987cites this paper
• Impaired immunoglobulin synthesis in multiple myeloma: A B‐cell dysfunction

  1986cites this paper
• Amyloidosis: an overview.

  1986cites this paper
• [Silent onset of multiple myeloma. How to diagnosis and when to treat?].

  1986cites this paper
• Abnormality in immunoregulatory cells in human malignancies.

  1986cites this paper
• Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.

  1986cites this paper
• MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.

  1986cites this paper
• Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.

  1986cites this paper
• Analysis of the subsets of Leu-7+ cells in myeloma and their effects on NK cell activity and Ig synthesis by B cells

  1986cites this paper
• Etiologic aspects of cold agglutinin disease: evidence for cytogenetically defined clones of lymphoid cells and the demonstration that an anti-Pr cold autoantibody is derived from a chromosomally aberrant B cell clone.

  1986cites this paper
• Autologous mixed lymphocyte reaction in multiple myeloma patients: effect of adherent mononuclear cells and T lymphocytes.

  1986cites this paper
• [Immunologic and ultrastructural study of a non-secretor IgG multiple myeloma].

  1985cites this paper
• [Possibility of complete recovery in multiple myeloma].

  1985cites this paper
• [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].

  1985cites this paper
• Extramedullary plasmacytoma of the parotid gland: report of a case and review of the literature.

  1985cites this paper
• Treatment strategies for plasma cell myeloma

  1985cites this paper
• Monoclonal Gammopathy (IgM-k) in a Patient with Burkitt's Type Lymphoblastic Lymphoma

  1984cites this paper
• On a mechanism of low level of Ig in a patient with multiple myeloma

  1984cites this paper
• [Analysis of prognostic factors in plasmacytoma].

  1984cites this paper
• Wertigkeit der quantitativen ß 2-Mikroglobulin- und Paraprotein-Bestimmung im Serum von Patienten mit multiplem Myelom und Waldenströms Makroglobulinämie

  1984cites this paper
• Analyse prognostischer Faktoren beim Plasmozytom

  1984cites this paper
• [Clinical staging and course evaluation of patients with multiple myeloma and benign monoclonal hyperglobulinemia using the Salmon-Wampler total tumor cell mass calculation].

  1984cites this paper
• Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.

  1984cites this paper
• Multiple myeloma.

  1984cites this paper
• [Smoldering indolent multiple myeloma].

  1983cites this paper
• Alpha‐chain disease without qualitative serum IgA abnormality: Report of two cases, including a “nonsecretory” form

  1983cites this paper
• Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma

  1983cites this paper
• Analysis of the reliability of serial paraprotein determinations in patients with plasma cell dyscrasias.

  1983cites this paper
• [Causes of death in cases of lymphoma, myeloma and Hodgkin disease. Study of 218 cases].

  1983cites this paper
• Discriminant analysis of parameters referring to the monoclonal cellular event in multiple myeloma and benign monoclonal gammopathy.

  1982cites this paper
• Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

  1982cites this paper
• In vitro cloning and chemosensitivity of human myeloma stem cells.

  1982cites this paper
• [Terminal stage of paraproteinemic hemoblastoses (clinico-morphologic and immunologic characteristics)].

  1982cites this paper
• Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy.

  1982cites this paper
• Myeloma protein kinetics following chemotherapy.

  1982cites this paper
• [Therapy of paraproteinemic hemoblastoses].

  1982cites this paper
• Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging

  1982cites this paper